Do analysts rate DFNS or SYPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Sypris Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is DFNS or SYPR more profitable?

Nukkleus has a net margin of 0.00% compared to Sypris Solutions' net margin of -9.23%. Sypris Solutions' return on equity of -67.14% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -26.92% Sypris Solutions -9.23% -67.14% -9.87%

Do analysts rate ZENA or DFNS?

ZenaTech currently has a consensus target price of $4.50, indicating a potential upside of 163.16%. Given ZenaTech's higher probable upside, analysts clearly believe ZenaTech is more favorable than Nukkleus. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZenaTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is ZENA or DFNS more profitable?

Nukkleus has a net margin of 0.00% compared to ZenaTech's net margin of -332.51%. ZenaTech's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets ZenaTech -332.51% N/A -78.90% Nukkleus N/A -190.60% -26.92%

Does the media refer more to ZENA or DFNS?

In the previous week, Nukkleus had 4 more articles in the media than ZenaTech. MarketBeat recorded 13 mentions for Nukkleus and 9 mentions for ZenaTech. ZenaTech's average media sentiment score of 0.80 beat Nukkleus' score of 0.59 indicating that ZenaTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ZenaTech 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nukkleus 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend VTSI or DFNS?

VirTra presently has a consensus target price of $5.00, suggesting a potential upside of 63.93%. Given VirTra's higher probable upside, equities analysts clearly believe VirTra is more favorable than Nukkleus. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VirTra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is VTSI or DFNS more profitable?

Nukkleus has a net margin of 0.00% compared to VirTra's net margin of -17.04%. VirTra's return on equity of -6.59% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets VirTra -17.04% -6.59% -4.57% Nukkleus N/A -190.60% -26.92%

Do analysts prefer VWAV or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VisionWave 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better earnings & valuation, VWAV or DFNS?

VisionWave is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VisionWave N/A N/A N/A -$2.31 N/A Nukkleus N/A N/A $78.55M -$397.10 N/A

Is VWAV or DFNS more profitable?

VisionWave's return on equity of -84.95% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets VisionWave N/A -84.95% -56.94% Nukkleus N/A -190.60% -26.92%

Does the media refer more to VWAV or DFNS?

In the previous week, Nukkleus had 11 more articles in the media than VisionWave. MarketBeat recorded 13 mentions for Nukkleus and 2 mentions for VisionWave. VisionWave's average media sentiment score of 0.94 beat Nukkleus' score of 0.59 indicating that VisionWave is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VisionWave 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nukkleus 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate DFNS or EURK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Eureka Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, DFNS or EURK?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nukkleus N/A N/A $78.55M -$397.10 N/A Eureka Acquisition N/A N/A N/A N/A N/A

Is DFNS or EURK more profitable?

Eureka Acquisition's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -26.92% Eureka Acquisition N/A N/A N/A

Nukkleus (DFNS) Competitors

$12.19 0.00 (0.00%)

As of 08/28/2026 04:00 PM Eastern

Compare

DFNS vs. SYPR, ZENA, VTSI, VWAV, and EURK

Should you buy Nukkleus stock or one of its competitors? Nukkleus's main competitors and comparable companies include Sypris Solutions (SYPR), ZenaTech (ZENA), VirTra (VTSI), VisionWave (VWAV), and Eureka Acquisition (EURK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "aerospace & defense" industry.

How does Nukkleus compare to Sypris Solutions?

Nukkleus (NASDAQ:DFNS) and Sypris Solutions (NASDAQ:SYPR) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sypris Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 44.7% of Sypris Solutions shares are owned by institutional investors. 11.1% of Nukkleus shares are owned by company insiders. Comparatively, 47.9% of Sypris Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nukkleus has a net margin of 0.00% compared to Sypris Solutions' net margin of -9.23%. Sypris Solutions' return on equity of -67.14% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-26.92%
Sypris Solutions	-9.23%	-67.14%	-9.87%

Nukkleus has a beta of -5.8, suggesting that its stock price is 680% less volatile than the broader market. Comparatively, Sypris Solutions has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

In the previous week, Nukkleus had 12 more articles in the media than Sypris Solutions. MarketBeat recorded 13 mentions for Nukkleus and 1 mentions for Sypris Solutions. Sypris Solutions' average media sentiment score of 1.45 beat Nukkleus' score of 0.59 indicating that Sypris Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Nukkleus	Positive
Sypris Solutions	Positive

Nukkleus has higher earnings, but lower revenue than Sypris Solutions. Sypris Solutions is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	N/A	N/A	$78.55M	-$397.10	N/A
Sypris Solutions	$119.89M	0.33	-$6.34M	-$0.47	N/A

Summary

Sypris Solutions beats Nukkleus on 8 of the 14 factors compared between the two stocks.

How does Nukkleus compare to ZenaTech?

ZenaTech (NASDAQ:ZENA) and Nukkleus (NASDAQ:DFNS) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Nukkleus has a net margin of 0.00% compared to ZenaTech's net margin of -332.51%. ZenaTech's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ZenaTech	-332.51%	N/A	-78.90%
Nukkleus	N/A	-190.60%	-26.92%

ZenaTech currently has a consensus target price of $4.50, indicating a potential upside of 163.16%. Given ZenaTech's higher probable upside, analysts clearly believe ZenaTech is more favorable than Nukkleus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ZenaTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Nukkleus had 4 more articles in the media than ZenaTech. MarketBeat recorded 13 mentions for Nukkleus and 9 mentions for ZenaTech. ZenaTech's average media sentiment score of 0.80 beat Nukkleus' score of 0.59 indicating that ZenaTech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ZenaTech	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nukkleus	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Nukkleus has lower revenue, but higher earnings than ZenaTech. ZenaTech is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ZenaTech	$20.18M	1.91	-$32.36M	-$1.42	N/A
Nukkleus	N/A	N/A	$78.55M	-$397.10	N/A

ZenaTech has a beta of 7.14, suggesting that its stock price is 614% more volatile than the broader market. Comparatively, Nukkleus has a beta of -5.8, suggesting that its stock price is 680% less volatile than the broader market.

12.5% of Nukkleus shares are owned by institutional investors. 11.1% of Nukkleus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Nukkleus beats ZenaTech on 9 of the 16 factors compared between the two stocks.

How does Nukkleus compare to VirTra?

VirTra (NASDAQ:VTSI) and Nukkleus (NASDAQ:DFNS) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Nukkleus has lower revenue, but higher earnings than VirTra. VirTra is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VirTra	$22.40M	1.54	$260K	-$0.26	N/A
Nukkleus	N/A	N/A	$78.55M	-$397.10	N/A

Nukkleus has a net margin of 0.00% compared to VirTra's net margin of -17.04%. VirTra's return on equity of -6.59% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VirTra	-17.04%	-6.59%	-4.57%
Nukkleus	N/A	-190.60%	-26.92%

In the previous week, Nukkleus had 11 more articles in the media than VirTra. MarketBeat recorded 13 mentions for Nukkleus and 2 mentions for VirTra. VirTra's average media sentiment score of 1.44 beat Nukkleus' score of 0.59 indicating that VirTra is being referred to more favorably in the media.

Company	Overall Sentiment
VirTra	Positive
Nukkleus	Positive

VirTra has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Nukkleus has a beta of -5.8, suggesting that its share price is 680% less volatile than the broader market.

VirTra presently has a consensus target price of $5.00, suggesting a potential upside of 63.93%. Given VirTra's higher probable upside, equities analysts clearly believe VirTra is more favorable than Nukkleus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VirTra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

14.7% of VirTra shares are held by institutional investors. Comparatively, 12.5% of Nukkleus shares are held by institutional investors. 3.5% of VirTra shares are held by insiders. Comparatively, 11.1% of Nukkleus shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

VirTra beats Nukkleus on 9 of the 16 factors compared between the two stocks.

How does Nukkleus compare to VisionWave?

VisionWave (NASDAQ:VWAV) and Nukkleus (NASDAQ:DFNS) are both small-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

VisionWave has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Nukkleus has a beta of -5.8, meaning that its stock price is 680% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VisionWave	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

VisionWave's return on equity of -84.95% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VisionWave	N/A	-84.95%	-56.94%
Nukkleus	N/A	-190.60%	-26.92%

VisionWave is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VisionWave	N/A	N/A	N/A	-$2.31	N/A
Nukkleus	N/A	N/A	$78.55M	-$397.10	N/A

51.4% of VisionWave shares are owned by institutional investors. Comparatively, 12.5% of Nukkleus shares are owned by institutional investors. 12.6% of VisionWave shares are owned by company insiders. Comparatively, 11.1% of Nukkleus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Nukkleus had 11 more articles in the media than VisionWave. MarketBeat recorded 13 mentions for Nukkleus and 2 mentions for VisionWave. VisionWave's average media sentiment score of 0.94 beat Nukkleus' score of 0.59 indicating that VisionWave is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VisionWave	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nukkleus	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

VisionWave beats Nukkleus on 6 of the 11 factors compared between the two stocks.

How does Nukkleus compare to Eureka Acquisition?

Nukkleus (NASDAQ:DFNS) and Eureka Acquisition (NASDAQ:EURK) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Nukkleus has a beta of -5.8, suggesting that its share price is 680% less volatile than the broader market. Comparatively, Eureka Acquisition has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market.

In the previous week, Nukkleus had 12 more articles in the media than Eureka Acquisition. MarketBeat recorded 13 mentions for Nukkleus and 1 mentions for Eureka Acquisition. Eureka Acquisition's average media sentiment score of 1.87 beat Nukkleus' score of 0.59 indicating that Eureka Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Nukkleus	Positive
Eureka Acquisition	Very Positive

12.5% of Nukkleus shares are owned by institutional investors. 11.1% of Nukkleus shares are owned by insiders. Comparatively, 34.5% of Eureka Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Eureka Acquisition's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-26.92%
Eureka Acquisition	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Eureka Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	N/A	N/A	$78.55M	-$397.10	N/A
Eureka Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

Eureka Acquisition beats Nukkleus on 5 of the 9 factors compared between the two stocks.

Get Nukkleus News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DFNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DFNS vs. The Competition

Export

Metric	Nukkleus	Aerospace & Defense Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$12.31M	$22.00B	$10.59B	$12.88B
Dividend Yield	N/A	1.65%	97.24%	11.27%
P/E Ratio	-0.03	39.91	26.37	25.45
Price / Sales	N/A	149.56	370.72	103.78
Price / Cash	0.03	28.38	24.21	36.03
Price / Book	-0.13	7.96	5.03	6.36
Net Income	$78.55M	$566.76M	$610.96M	$349.79M
7 Day Performance	10.72%	-1.22%	-0.34%	-0.48%
1 Month Performance	-55.96%	2.02%	1.98%	4.17%
1 Year Performance	-98.00%	11.93%	10.96%	15.11%

Nukkleus Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DFNS Nukkleus	1.1936 of 5 stars	$12.19 flat	N/A	-98.0%	$12.31M	N/A	N/A	12	Short Interest Decrease
SYPR Sypris Solutions	0.9321 of 5 stars	$1.80 flat	N/A	-9.8%	$41.45M	$119.89M	N/A	680
ZENA ZenaTech	3.2959 of 5 stars	$1.83 +2.2%	$4.50 +145.9%	-65.3%	$41.18M	$20.18M	N/A	11	Gap Up
VTSI VirTra	3.5521 of 5 stars	$3.09 +3.3%	$5.00 +61.8%	-49.0%	$34.98M	$22.40M	N/A	120	Positive News
VWAV VisionWave	0.8408 of 5 stars	$1.09 -3.5%	N/A	N/A	$31.44M	N/A	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DFNS) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nukkleus (DFNS) Competitors

DFNS vs. SYPR, ZENA, VTSI, VWAV, and EURK

How does Nukkleus compare to Sypris Solutions?

Summary

How does Nukkleus compare to ZenaTech?

Summary

How does Nukkleus compare to VirTra?

Summary

How does Nukkleus compare to VisionWave?

Summary

How does Nukkleus compare to Eureka Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nukkleus (DFNS) Competitors

DFNS vs. SYPR, ZENA, VTSI, VWAV, and EURK

How does Nukkleus compare to Sypris Solutions?

Do analysts rate DFNS or SYPR?

Do insiders & institutionals believe in DFNS or SYPR?

Is DFNS or SYPR more profitable?

Which has more risk and volatility, DFNS or SYPR?

Does the media favor DFNS or SYPR?

Which has stronger earnings & valuation, DFNS or SYPR?

Summary

How does Nukkleus compare to ZenaTech?

Is ZENA or DFNS more profitable?

Do analysts rate ZENA or DFNS?

Does the media refer more to ZENA or DFNS?

Which has higher valuation & earnings, ZENA or DFNS?

Which has more volatility and risk, ZENA or DFNS?

Do insiders and institutionals believe in ZENA or DFNS?

Summary

How does Nukkleus compare to VirTra?

Which has preferable valuation & earnings, VTSI or DFNS?

Is VTSI or DFNS more profitable?

Does the media refer more to VTSI or DFNS?

Which has more volatility & risk, VTSI or DFNS?

Do analysts recommend VTSI or DFNS?

Do insiders & institutionals have more ownership in VTSI or DFNS?

Summary

How does Nukkleus compare to VisionWave?

Which has more volatility & risk, VWAV or DFNS?

Do analysts prefer VWAV or DFNS?

Is VWAV or DFNS more profitable?

Which has better earnings & valuation, VWAV or DFNS?

Do insiders & institutionals have more ownership in VWAV or DFNS?

Does the media refer more to VWAV or DFNS?

Summary

How does Nukkleus compare to Eureka Acquisition?

Which has more risk and volatility, DFNS or EURK?

Does the media prefer DFNS or EURK?

Do insiders & institutionals believe in DFNS or EURK?

Is DFNS or EURK more profitable?

Do analysts rate DFNS or EURK?

Which has better valuation and earnings, DFNS or EURK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools